Show
Sort by
-
- Journal Article
- A1
- open access
Therapeutic depletion of CCR8(+) tumor-infiltrating regulatory T cells elicits antitumor immunity and synergizes with anti-PD-1 therapy
-
Single-cell profiling of myeloid cells in glioblastoma across species and disease stage reveals macrophage competition and specialization
-
- Journal Article
- A1
- open access
Neurocognitive function, psychosocial outcome, and health-related quality of life of the first-generation metastatic melanoma survivors treated with Ipilimumab
-
An atypical sarcoid-like reaction during anti-protein death 1 treatment in a patient with metastatic melanoma
-
A randomized controlled phase II clinical trial on mRNA electroporated autologous monocyte-derived dendritic cells (TriMixDC-MEL) as adjuvant treatment for stage III/IV melanoma patients who are disease-free following the resection of macrometastases
-
Phase 2 trial of nivolumab combined with stereotactic body radiation therapy in patients with metastatic or locally advanced inoperable melanoma
-
Immune cell profiling of melanoma metastases from patients treated with TriMixDC-MEL dendritic cell therapy in combination with ipilimumab
-
- Journal Article
- A1
- open access
Molecular and epigenetic features of melanomas and tumor immune microenvironment linked to durable remission to ipilimumab-based immunotherapy in metastatic patients
-
- Journal Article
- A1
- open access
Clinical significance of plasmacytoid dendritic cells and myeloid-derived suppressor cells in melanoma
-
Systemic immune changes associated with adjuvant interferon-α2b-therapy in stage III melanoma patients: failure at the effector phase?